Skip to content
Mental Health — Muscarinic antipsychotics

Xanomeline–trospium

Prescription only

First new kind of schizophrenia drug in decades.

Starts working
Varies
Half-life
—
In use since
2024
Pregnancy
Use with caution

Overview

Approved in the US in September 2024, Cobenfy is the first schizophrenia medicine that doesn't work by blocking dopamine. In trials it reduced psychotic symptoms without the weight gain, stiffness or prolactin rise typical of antipsychotics, but causes nausea, constipation and other gut effects.

Conditions it's used for

How it works

Switches on brain receptors that indirectly calm dopamine, while a second ingredient blocks gut side effects.

Xanomeline–trospium belongs to the Muscarinic antipsychotics. How Muscarinic antipsychotics work: switch on muscarinic receptors in the brain that indirectly calm dopamine pathways; a second ingredient blocks the same receptors in the body to reduce gut side effects.

Uses

  • Schizophrenia in adults

Available as: capsule.

Typical dose

Adults
Start 50/20 mg twice a day, increasing to 100/20 then up to 125/30 mg twice a day, at least 1 hour before or 2 hours after food.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Nausea
  • Indigestion
  • Constipation
  • Vomiting
  • Raised heart rate
  • Dizziness

Serious — get medical help

Uncommon, but need prompt attention

  • Urinary retention
  • Angioedema
  • Raised liver enzymes

Warnings

  • Take on an empty stomach
  • Not with significant liver disease or urinary retention
  • Caution with narrow-angle glaucoma

Interactions

  • Other anticholinergic drugs — more side effects
Check Xanomeline–trospium against your own medicines

Pregnancy and breastfeeding

Use with caution

Limited data.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Cobenfy

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

  1. 2024

    FDA approves Cobenfy on 26 September.

  2. 2025

    A trial adding it to existing antipsychotics (ARISE) missed its main goal.

Common questions

Does it cause weight gain?

In trials, weight gain was similar to placebo.

Do I need a prescription for Xanomeline–trospium?

Yes — Xanomeline–trospium is prescription-only in most countries.

Can I take Xanomeline–trospium during pregnancy?

Use with caution. Limited data. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.